Previous Next

2024-02-28

Oral anticoagulants or warfarin in stroke prevention

Pharmacology and Toxicology

In this observational cohort study conducted in Denmark, Sweden, Norway and Finland, 26,883 patients treated with reduced-dose oral anticoagulants (dagibatran, rivaroxaban, apixaban) and 108,014 patients treated with warfarin were followed. The aim of the study was to assess the efficacy and safety of reduced-dose oral anticoagulants in stroke prevention in patients with atrial fibrillation. Similar or lower incidences of stroke and embolism were observed in patients receiving reduced-dose oral anticoagulants, compared with warfarin. Intracranial hemorrhage rates were generally low, ranging from 0.16 to 1.85 per 100 person-years.

Source(s) :
: Flemming Skjøth et al. Comparative safety and effectiveness of reduced doses of direct acting oral anticoagulants for stroke prevention in atrial fibrillation. Am J Med. 2024 Feb 20:S0002-9343(24)00098-6. ;

Last press reviews


Genes and Alzheimer’s: the key to the mystery?

#Alzheimer  #Genetics  #Neurodegeneration  #PrecisionMedi...

Postoperative delirium: does melatonin really work?

#Delirium  #Surgery  #Melatonin  #Prevention  #Cogni...

Vitamin D deficiency: a risk for the mind?

#Suicide  #VitaminD  #Depression  #Neuroprotection ...